PulseAugur
EN
LIVE 11:34:47

Dolph Lundgren discusses his kidney cancer battle and treatment

By PulseAugur Editorial · [1 sources] ·

Actor Dolph Lundgren has shared his journey with kidney cancer, which was first diagnosed in 2015. After initial treatment and being declared cancer-free, the cancer returned and spread significantly by 2020, affecting his spine, liver, and lungs. Lundgren underwent immunotherapy and sought a second opinion in the U.S. from Dr. Alexandra Drakaki at UCLA, who has since helped him manage the disease. AI

RANK_REASON This is a personal health narrative from a public figure, not a core AI development or industry event.

Read on Forbes — Innovation →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Dolph Lundgren discusses his kidney cancer battle and treatment

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Commentary
This is a personal health narrative from a public figure, not a core AI development or industry event.
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
57 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. Forbes — Innovation TIER_1 English(EN) · Bruce Y. Lee, Senior Contributor ·

    Dolph Lundgren Open Up About His Kidney Cancer Journey

    Here Dolph Lundgren discussed his kidney cancer diagnosis (specifically renal cell carcinoma) in 2015, its recurrence in 2020 and how a key ALK mutation was first missed.

RELATED ENTITIES

RELATED TOPICS